Profile data is unavailable for this security.
About the company
Emami Limited is an India-based company, which is focused on personal and healthcare businesses in India. The Company is engaged in the business of manufacturing health, beauty and personal care products. The Company’s brands, including BoroPlus, Navratna, Zandu, Fair and Handsome, Kesh King, Mentho plus balm, Dermicool, 7 Oils in One, HE, Diamond Shine, Emami Golden Beauty, Emami Naturally Fair, Emami Emasol and Creme21. It has a portfolio of over 300 + products based on ayurvedic formulations. Its operations comprise more than 60 countries, including SAARC, MENAP, SEA, Africa, Eastern Europe and the CIS countries. It provides Ayurvedic Antiseptic Cream, Prickly Heat Powder, Doodh Kesar Body Lotion, Vasocare Herbal Petroleum Jelly, Aloe Vera Gel, Hygiene Range, Cool Oil, Extra Thanda, Gold Ayurvedic Oil and others. It has manufacturing units in India and abroad to develop products suited to meet the diverse needs and preferences of consumers in different markets.
- Revenue in INR (TTM)35.23bn
- Net income in INR7.19bn
- Incorporated1983
- Employees3.24k
- LocationEmami LtdEmami Tower, 687 Anandapur,, EM BypassKOLKATA 700107IndiaIND
- Phone+91 3 366136264
- Fax+91 3 366136600
- Websitehttp://www.emamiltd.in/
Mergers & acquisitions
| Acquired company | EMAMILTD:NSI since announced | Transaction value |
|---|---|---|
| Brillare Science Pvt Ltd | 10.39% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TTK Prestige Ltd | 26.66bn | 2.29bn | 96.95bn | 1.42k | 42.29 | -- | 33.45 | 3.64 | 16.54 | 16.54 | 192.35 | -- | -- | -- | -- | 18,830,930.00 | -- | 11.81 | -- | 15.30 | 40.74 | 39.90 | 8.47 | 9.93 | -- | 20.39 | -- | 25.85 | 2.01 | 8.22 | -16.62 | -0.7177 | 41.17 | 19.14 |
| Jyothy Labs Ltd | 27.14bn | 3.51bn | 156.69bn | 2.60k | 44.64 | -- | 39.23 | 5.77 | 9.56 | 9.56 | 74.01 | -- | -- | -- | -- | 10,430,000.00 | -- | 9.71 | -- | 13.23 | 48.21 | 42.75 | 12.91 | 9.39 | -- | 62.76 | -- | 58.28 | 13.18 | 8.02 | 48.01 | 5.20 | -1.66 | 43.10 |
| Gillette India Limited | 25.46bn | 3.91bn | 202.26bn | 571.00 | 51.72 | 19.63 | 42.55 | 7.95 | 120.02 | 120.02 | 781.20 | 316.25 | 1.44 | 2.77 | 9.79 | 44,580,040.00 | 22.08 | 20.15 | 36.61 | 31.75 | 53.65 | 52.29 | 15.36 | 13.99 | 1.04 | 66.44 | 0.00005 | 75.43 | 9.79 | 8.12 | 22.93 | 9.20 | -0.5816 | 29.88 |
| Emami Ltd | 35.23bn | 7.19bn | 202.97bn | 3.24k | 28.32 | -- | 22.07 | 5.76 | 16.42 | 16.42 | 80.35 | -- | -- | -- | -- | 10,889,650.00 | -- | 17.98 | -- | 24.68 | 66.96 | 65.16 | 20.41 | 17.02 | -- | 67.15 | -- | 56.21 | 6.69 | 6.03 | -23.77 | 15.80 | -20.03 | -- |
| Procter & Gamble Hygiene & Health Care | 40.07bn | 7.56bn | 522.47bn | 432.00 | 69.12 | 49.64 | 64.15 | 13.04 | 232.85 | 232.85 | 1,234.55 | 324.24 | 1.89 | 8.37 | 14.50 | 92,763,890.00 | 35.73 | 32.29 | 70.38 | 57.68 | 59.08 | 49.02 | 18.86 | 15.90 | 1.34 | 81.77 | 0.0034 | 68.62 | 0.4353 | 9.80 | 17.78 | 12.60 | 3.12 | 35.84 |
| Colgate-Palmolive (India) Ltd | 55.41bn | 12.60bn | 761.46bn | 2.32k | 60.43 | -- | 53.15 | 13.74 | 46.33 | 46.33 | 203.74 | -- | -- | -- | -- | 23,904,430.00 | -- | 34.57 | -- | 58.72 | 69.08 | 59.75 | 22.74 | 19.68 | -- | 349.62 | -- | 101.29 | 2.48 | 3.84 | -2.89 | 9.23 | -19.62 | 10.20 |
| Dabur India Ltd | 122.67bn | 17.94bn | 897.45bn | 5.32k | 50.13 | -- | 41.61 | 7.32 | 10.10 | 10.10 | 69.06 | -- | -- | -- | -- | 23,054,260.00 | -- | 15.42 | -- | 21.53 | 47.41 | 48.10 | 14.37 | 16.32 | -- | 16.06 | -- | 46.05 | 5.79 | 8.27 | -1.84 | 4.74 | 19.72 | 15.77 |
| Holder | Shares | % Held |
|---|---|---|
| DSP Asset Managers Pvt. Ltd.as of 31 Mar 2024 | 21.00m | 4.81% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Mar 2024 | 13.19m | 3.02% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Mar 2024 | 8.78m | 2.01% |
| Kotak Mahindra Asset Management Co. Ltd.as of 31 Mar 2024 | 8.00m | 1.83% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 7.77m | 1.78% |
| HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 31 Mar 2024 | 6.82m | 1.56% |
| Mirae Asset Investment Managers (India) Pvt Ltd.as of 31 Mar 2024 | 6.09m | 1.40% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 Mar 2024 | 5.89m | 1.35% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Mar 2024 | 5.75m | 1.32% |
| Invesco Advisers, Inc.as of 29 Feb 2024 | 5.45m | 1.25% |
